Stanford University
Showing 71-80 of 1,599 Results
-
Gita Chu Abhiraman
Affiliate, Department Funds
Resident in MedicineBioGita Abhiraman is a resident physician in Internal Medicine at Stanford in the Translational Investigator Program. She completed her MD and PhD at Stanford in the Medical Scientist Training Program. Her PhD in Immunology was advised by Dr. Chris Garcia, in which she studied cytokine signaling, immune receptor structure, and protein engineering. Her major first author-works include solving the structure of the interleukin-21 signaling receptor complex. She also developed a cytokine "adapter" switch molecule with applications in cancer and autoimmune disease. Gita has been involved in several projects to engineer cytokines, including IL-21, IL-12, and IL-10, for diverse therapeutic applications. Prior to her graduate training, Gita completed a bachelor's degree in Physics with a focus in Biophysics at Harvard University. She previously conducted research in the lab of Dr. Stephanie Dougan at the Dana-Farber Cancer Institute.
-
Matthew Alexander Abikenari
MD Student with Scholarly Concentration in Molecular Basis of Medicine / Immunology, expected graduation Spring 2028
BioMatthew received his undergraduate degree Summa Cum Laude from UCLA, where he conducted full-time basic and clinical neuroscience research on molecular mechanisms underlying neuropsychiatric and neurodegenerative disease. He then pursued a graduate degree in Clinical Neuroscience at the University of Oxford as The Queen’s College Herbruck Scholar, an award granted to only one American student per year, completing a thesis on paraneoplastic autoimmunity and the genotypic and phenotypic architecture of meningiomas, alongside RNA sequencing and spatial–genomic analyses of malignant CNS tumors. As a medical student at Stanford University, he joined Dr. Michael Lim’s laboratory, gaining extensive experience in in vitro and in vivo immunology, stereotactic tumor implantations, and high-throughput transcriptomics to define mechanisms of immunosuppression in glioblastoma. His family’s experience with brain cancer continues to ground his work and deepen his commitment to understanding, and ultimately improving, neurosurgical oncology.
-
Frank Abild-Pedersen
Senior Scientist, SLAC National Accelerator Laboratory
BioDr. Abild-Pedersen is the co-director of SUNCAT Center for Interface Science and Catalysis. He is leading a research team that focuses on developing an understanding of the factors determining the catalytic properties at the interface between gas/solvent and solid surfaces and to apply these insights to processes and catalysts of importance for energy transformations and for sustainable chemical production. His research takes advantage of computer facilities at SLAC and Stanford to gain the necessary understanding and to link these simulations to experiments where new catalyst synthesis methods are developed, and the catalyst materials are characterized both in terms of performance (activity, selectivity, durability, etc.) and in terms of geometrical and electronic structure. The underlying philosophy of his research is that by having a fundamental understanding of the way surfaces catalyze a chemical reaction we can make a quantum leap in our ability to make predictions for new catalysts and processes. This requires the development of a theory of heterogeneous catalysis, including electrocatalysis, based on computational and experimental results.
Dr Abild-Pedersen has extensive experience with simulations and modeling of chemical reactions. His work began with the derivation of energy correlations in catalysis that have helped speed up screening for active, selective and stable catalysts for energy conversion as a graduate student working with Professor Jens K. Nørskov at the Technical University of Denmark. He moved to SLAC in 2010 as a staff scientist and helped build up SUNCAT and define research directions in the field of heterogeneous catalysis. -
Oscar J. Abilez
Senior Scientist, Cardiothoracic Surgery - Pediatric Cardiac Surgery
Current Research and Scholarly InterestsDr. Abilez' interests are aimed at elucidating how various biophysical and biochemical perturbations regulate early cardiovascular development across time and length scales that span several orders of magnitude, using human pluripotent stem cells as a model system.
